These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23067317)

  • 1. Levofloxacin-containing triple and sequential therapy or standard sequential therapy as the first line treatment for Helicobacter pylori eradication in China.
    Qian J; Ye F; Zhang J; Yang YM; Tu HM; Jiang Q; Shang L; Pan XL; Shi RH; Zhang GX
    Helicobacter; 2012 Dec; 17(6):478-85. PubMed ID: 23067317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of second-line anti-Helicobacter pylori therapy using an extended 14-day levofloxacin/amoxicillin/proton-pump inhibitor treatment--a pilot study.
    Chuah SK; Tai WC; Hsu PI; Wu DC; Wu KL; Kuo CM; Chiu YC; Hu ML; Chou YP; Kuo YH; Liang CM; Chiu KW; Hu TH
    Helicobacter; 2012 Oct; 17(5):374-81. PubMed ID: 22967121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
    Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
    Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection.
    Federico A; Nardone G; Gravina AG; Iovene MR; Miranda A; Compare D; Pilloni PA; Rocco A; Ricciardiello L; Marmo R; Loguercio C; Romano M
    Gastroenterology; 2012 Jul; 143(1):55-61.e1; quize e13-4. PubMed ID: 22484118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
    Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
    Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
    Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori.
    Polat Z; Kadayifci A; Kantarcioglu M; Ozcan A; Emer O; Uygun A
    Eur J Intern Med; 2012 Mar; 23(2):165-8. PubMed ID: 22284248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong?
    Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC
    Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of two non-bismuth-containing second-line rescue therapies for Helicobacter pylori.
    Chuah SK; Hsu PI; Chang KC; Chiu YC; Wu KL; Chou YP; Hu ML; Tai WC; Chiu KW; Chiou SS; Wu DC; Hu TH
    Helicobacter; 2012 Jun; 17(3):216-23. PubMed ID: 22515360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study.
    Calhan T; Kahraman R; Sahin A; Senates E; Doganay HL; Kanat E; Ozdil K; Sokmen HM
    Helicobacter; 2013 Oct; 18(5):378-83. PubMed ID: 23601026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
    Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
    Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.
    Cuadrado-Lavín A; Salcines-Caviedes JR; Carrascosa MF; Dierssen-Sotos T; Cobo M; Campos MR; Ayestarán B; Fernández-Pousa A; González-Colominas E; Aresti-Zárate S; Hernández M; Pascual EL
    J Antimicrob Chemother; 2012 Sep; 67(9):2254-9. PubMed ID: 22687889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
    Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
    Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-week once-daily triple therapy with esomeprazole, levofloxacin and azithromycin compared to a standard therapy for Helicobacter pylori eradication.
    Iacopini F; Crispino P; Paoluzi OA; Consolazio A; Pica R; Rivera M; Palladini D; Nardi F; Paoluzi P
    Dig Liver Dis; 2005 Aug; 37(8):571-6. PubMed ID: 15996628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
    Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
    Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial.
    Liou JM; Chen CC; Chen MJ; Chang CY; Fang YJ; Lee JY; Sheng WH; Wang HP; Wu MS; Lin JT
    J Antimicrob Chemother; 2011 Aug; 66(8):1847-52. PubMed ID: 21632579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study].
    Cheng H; Hu FL; Zhang GX; Shi RH; Du YQ; Li ZS; Han W; Li YQ; Wu QD; Qian KD
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):79-82. PubMed ID: 20356486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
    Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP
    Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study.
    Chen LW; Chien RN; Chang JJ; Fang KM; Chang LC
    Int J Clin Pract; 2010 Oct; 64(11):1530-1534. PubMed ID: 20846200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication.
    Ozdil K; Calhan T; Sahin A; Senates E; Kahraman R; Yüzbasioglu B; Demirdag H; Demirsoy H; Sökmen MH
    Hepatogastroenterology; 2011; 58(109):1148-52. PubMed ID: 21937367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.